Advertisement
U.S. Markets close in 5 hrs 1 min

RPG Life Sciences Limited (RPGLIFE.NS)

NSE - NSE Real Time Price. Currency in INR
2,594.60-155.25 (-5.65%)
At close: 03:29PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 45.48B
Enterprise Value 44.22B
Trailing P/E 49.25
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.64
Price/Book (mrq)12.13
Enterprise Value/Revenue 7.43
Enterprise Value/EBITDA 30.98

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32,974.95
52 Week Low 31,292.00
50-Day Moving Average 32,343.00
200-Day Moving Average 31,769.36

Share Statistics

Avg Vol (3 month) 348.68k
Avg Vol (10 day) 341.05k
Shares Outstanding 516.54M
Implied Shares Outstanding 6N/A
Float 84.32M
% Held by Insiders 170.66%
% Held by Institutions 18.38%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 416
Forward Annual Dividend Yield 40.58%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.75
Payout Ratio 450.15%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 28, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 15.40%
Operating Margin (ttm)20.42%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)6B
Revenue Per Share (ttm)362.61
Quarterly Revenue Growth (yoy)11.90%
Gross Profit (ttm)N/A
EBITDA 1.33B
Net Income Avi to Common (ttm)923.2M
Diluted EPS (ttm)55.82
Quarterly Earnings Growth (yoy)21.10%

Balance Sheet

Total Cash (mrq)1.26B
Total Cash Per Share (mrq)76.11
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)226.65

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A